{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:46:54Z","timestamp":1792442814446,"version":"4.5.0"},"reference-count":90,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin","award":["DS334\/2019-21"],"award-info":[{"award-number":["DS334\/2019-21"]}]},{"name":"Medical University of Lublin","award":["DS640"],"award-info":[{"award-number":["DS640"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The purpose of this study was to evaluate serum levels of anti- and pro-angiogenic substances measured using enzyme-linked immunosorbent assays and their ratios in pregnancies complicated by different clinical subsets of placental ischemic syndrome: preeclampsia and\/or fetal growth restriction. A prospective case-control study was performed consisting of 77 singleton pregnancies complicated by preeclampsia, preeclampsia with concurrent fetal growth restriction (FGR), and isolated normotensive FGR pairwise matched by gestational age with healthy pregnancies. The entire study cohort was analyzed with respect to adverse pregnancy outcomes that occurred. In all investigated subgroups, placental growth factor (PlGF) was lower and soluble endoglin (sEng), the soluble fms-like tyrosine kinase-1\u2014sFlt-1\/PlGF and sFlt-1*sEng\/PlGF ratios were higher than in the control group. The differences were most strongly pronounced in the PE with concurrent FGR group and in the sFlt-1\/PlGF ratio. The highest sFlt-1 values in preeclamptic patients suggest that this substance may be responsible for reaching the threshold needed for PE to develop as a maternal manifestation of ischemic placental disease. The FGR is characterized by an elevated maternal sFlt-1\/PlGF ratio, which boosts at the moment of indicated delivery due to fetal risk. We concluded that angiogenic imbalance is reflective of placental disease regardless of its clinical manifestation in the mother, and may be used as support for the diagnosis and prognosis of FGR.<\/jats:p>","DOI":"10.3390\/ijms24020972","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:12:15Z","timestamp":1672888335000},"page":"972","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0822-0350","authenticated-orcid":false,"given":"Weronika","family":"Dymara-Konopka","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Perinatology, Medical University of Lublin, 8 Jaczewskiego Street, 20-095 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2602-4249","authenticated-orcid":false,"given":"Marzena","family":"Laskowska","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Perinatology, Medical University of Lublin, 8 Jaczewskiego Street, 20-095 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4741","authenticated-orcid":false,"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 4a Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hymos","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 4a Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-5831","authenticated-orcid":false,"given":"Anna","family":"B\u0142a\u017cewicz","sequence":"additional","affiliation":[{"name":"Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Biomedical Sciences, Medical University of Lublin, 1 Chod\u017aki Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Leszczy\u0144ska-Gorzelak","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Perinatology, Medical University of Lublin, 8 Jaczewskiego Street, 20-095 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: A systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0140-6736(10)62187-3","article-title":"Stillbirths: Where? When? Why? How to make the data count?","volume":"377","author":"Lawn","year":"2011","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/uog.12537","article-title":"First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler","volume":"43","author":"Crovetto","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): A randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ajog.2004.10.621","article-title":"Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?","volume":"192","author":"Shear","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Weiler, J., Tong, S., and Palmer, K.R. (2011). Is Fetal Growth Restriction Associated with a More Severe Maternal Phenotype in the Setting of Early Onset Pre-Eclampsia? A Retrospective Study. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026937"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)06297-6","article-title":"Ambulatory blood pressure in pregnancy and fetal growth","volume":"349","author":"Churchill","year":"1997","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1479-828X.2001.tb01294.x","article-title":"Abnormal uterine artery Doppler in small-for-gestational-age pregnancies is asso-ciated with later hypertension","volume":"41","author":"McCowan","year":"2001","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1447-0756.2009.01120.x","article-title":"Clinical features of fetal growth restriction complicated later by preeclampsia","volume":"35","author":"Mitani","year":"2009","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bpobgyn.2016.10.006","article-title":"An integrated approach to fetal growth restriction","volume":"38","author":"Figueras","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kwiatkowski, S., Do\u0142\u0119gowska, B., Kwiatkowska, E., Rzepka, R., Torb\u00e8, A., and Bednarek-J\u0119drzejek, M. (2016). A Common Profile of Dis-ordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0165060"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2015","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440650","article-title":"Angiogenic Factors and Doppler Evaluation in Normally Growing Fetuses at Routine Third-Trimester Scan: Prediction of Subsequent Low Birth Weight","volume":"40","author":"Triunfo","year":"2015","journal-title":"Fetal Diagn. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","article-title":"Characterization of the soluble fms-like Tyro-sine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Compliated by Fetal Growth Restriction","volume":"124","author":"Herraiz","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.semperi.2014.03.001","article-title":"Ischemic placental disease: A unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption","volume":"38","author":"Ananth","year":"2014","journal-title":"Semin. Perinatol."},{"key":"ref_16","first-page":"2033","article-title":"Ischemic placental syndrome-Prediction and new disease monitoring","volume":"29","author":"Kwiatkowski","year":"2016","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","article-title":"A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate","volume":"21","author":"Romero","year":"2008","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9378(98)70021-3","article-title":"Preeclampsia is associated with reduced serum levels of placenta growth factor","volume":"179","author":"Torry","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1471-0528.1999.tb08107.x","article-title":"Selectivedeficit of angiogenic growth factors char-acterises pregnancies complicated by pre-eclampsia","volume":"106","author":"Reuvekamp","year":"1999","journal-title":"Br. J. Obstet Gynaecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1067\/mob.2001.113129","article-title":"Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia","volume":"184","author":"Tidwell","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of pla-cental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating Angiogenic Factors and the Risk of Preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajog.2005.06.033","article-title":"An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia","volume":"193","author":"Park","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2007.05.022","article-title":"Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia","volume":"197","author":"Unal","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"550.e1","DOI":"10.1016\/j.ajog.2010.04.002","article-title":"A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia","volume":"202","author":"Chaiworapongsa","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20110097","article-title":"Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia","volume":"122","author":"Verlohren","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/jc.2003-030528","article-title":"Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences","volume":"88","author":"Tsatsaris","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1172\/JCI18015","article-title":"Soluble VEGF receptor Flt1: The elusive preeclampsia factor discovered?","volume":"111","author":"Luttun","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.earlhumdev.2005.09.010","article-title":"Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates","volume":"82","author":"Boutsikou","year":"2006","journal-title":"Early Hum. Dev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ajog.2006.03.065","article-title":"Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction","volume":"195","author":"Savvidou","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: Correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/CS20060161","article-title":"Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction","volume":"112","author":"Wallner","year":"2006","journal-title":"Clin. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14767050701832833","article-title":"The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14767050701831397","article-title":"Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/aje\/kwq373","article-title":"Angiogenic Factors in Maternal Circulation and the Risk of Severe Fetal Growth Restriction","volume":"173","author":"Vatten","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sibiude, J., Guibourdenche, J., Dionne, M.-D., Le Ray, C., Anselem, O., Serreau, R., Goffinet, F., and Tsatsaris, V. (2012). Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050208"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"and the CHIPS Study Group. Less-tight versus tight control of hypertension in preg-nancy","volume":"372","author":"Magee","year":"2015","journal-title":"N. Eng. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/pd.4401","article-title":"Treatment of poor placentation and the prevention of associated adverse outcomes\u2014What does the future hold?","volume":"34","author":"Spencer","year":"2014","journal-title":"Prenat Diagn."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa041367","article-title":"Neurologic and developmental disability at six years of age after ex-tremely preterm birth","volume":"352","author":"Marlow","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/uog.7321","article-title":"Early intervention in management of very preterm growth-restricted fetuses: 2-year outcome of infants delivered on fetal indication before 30 gestational weeks","volume":"34","author":"Brodszki","year":"2009","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1542\/peds.2010-1821","article-title":"Cognitive Function After Intrauterine Growth Restriction and Very Preterm Birth","volume":"127","author":"Morsing","year":"2011","journal-title":"Pediatrics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiology.181.1.1887021","article-title":"In utero analysis of fetal growth: A sonographic weight standard","volume":"181","author":"Hadlock","year":"1991","journal-title":"Radiology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/uog.19073","article-title":"Fetal Medicine Foundation fetal and neonatal population weight charts","volume":"52","author":"Nicolaides","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: Implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1\/PlGF Ratio in Singleton Pregnancies","volume":"43","author":"Herraiz","year":"2017","journal-title":"Fetal Diagn. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/jog.13452","article-title":"Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and\/or fetal growth restriction","volume":"43","author":"Nanjo","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2004-1955","article-title":"Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor","volume":"90","author":"Shibata","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/14767058.2014.880882","article-title":"Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles","volume":"27","author":"Alahakoon","year":"2014","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1210\/jc.2006-2774","article-title":"Maternal Plasma Concentrations of Soluble Endoglin in Pregnancies with Intrauterine Growth Restriction","volume":"92","author":"Stepan","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0029-1224142","article-title":"Angiogenic factors and their role in pathogenesis and prediction of preeclampsia","volume":"213","author":"Stepan","year":"2009","journal-title":"Z. Geburtshilfe Neonatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/14767058.2011.595852","article-title":"Endoglin in pregnancy complicated by fetal IUGR in normotensive and preeclamptic pregnant women: A comparison between preeclamptic patients with appropriate-for-gestational-age weight in-fants and healthy pregnant women","volume":"25","author":"Laskowska","year":"2012","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcm.2018.04.009","article-title":"Preeclampsia and the cardiovascular system: An update","volume":"28","author":"Perry","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/uog.19081","article-title":"Pre-eclampsia and the cardiovascular-placental axis","volume":"51","author":"Thilaganathan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1753944708094227","article-title":"Review: Preeclampsia and future cardiovascular risk: Formal risk factor or failed stress test?","volume":"2","author":"Craici","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.107.100248","article-title":"Preeclampsia more than 1 disease: Or is it?","volume":"51","author":"Roberts","year":"2008","journal-title":"Hypertension"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.semperi.2014.03.002","article-title":"Prediction and prevention of ischemic placental disease","volume":"38","author":"Friedman","year":"2014","journal-title":"Semin. Perinatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/pd.4412","article-title":"Stage-based approach to the management of fetal growth restriction","volume":"34","author":"Figueras","year":"2014","journal-title":"Prenat. Diagn."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"398e40","DOI":"10.1016\/j.placenta.2014.03.021","article-title":"Angiogenic factors at late-onset small for gestational age and histological placental under perfusion","volume":"35","author":"Triunfo","year":"2014","journal-title":"Placenta"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2352-4642(18)30129-9","article-title":"Screening for fetal growth restriction using ultrasound and the sFLT1\/PlGF ratio in nulliparous women: A prospective cohort study","volume":"2","author":"Gaccioli","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/uog.21949","article-title":"sFlt-1\/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow","volume":"56","author":"Quezada","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/aogs.14032","article-title":"Individual risk assessment for prenatal counseling in early-onset growth-restricted and small-for-gestational-age fetuses","volume":"100","author":"Mendoza","year":"2020","journal-title":"Acta Obstet. et Gynecol. Scand."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2016.08.036","article-title":"Italian advisory board: sFlt-1\/ PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management","volume":"206","author":"Cetin","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1210\/en.2007-0180","article-title":"Vasoactive and Permeability Effects of Vascular Endothelial Growth Factor-165 in the Term in Vitro Dually Perfused Human Placental Lobule","volume":"148","author":"Brownbill","year":"2007","journal-title":"Endocrinology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.1711260306","article-title":"Ultrastructure of the placenta in prolonged pregnancy","volume":"126","author":"Jones","year":"1978","journal-title":"J. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1047e52","DOI":"10.1067\/S0002-9378(03)00897-4","article-title":"What is the best measure of maternal complications of term pregnancy: Ongoing pregnancies or pregnancies delivered?","volume":"189","author":"Caughey","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/10641950902777697","article-title":"Late Onset Preeclampsia is not an Innocuous Condition","volume":"29","author":"Kenneth","year":"2010","journal-title":"Hypertens. Pregnancy"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1515\/jpm-2013-0074","article-title":"The importance of repeated measurements of the sFlt-1\/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction","volume":"42","author":"Schoofs","year":"2014","journal-title":"J. Perinat. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: A Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13522","article-title":"FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction","volume":"152","author":"Melamed","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/HYPERTENSIONAHA.116.07862","article-title":"The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?","volume":"68","author":"Magee","year":"2016","journal-title":"Hypertension"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.semperi.2009.02.009","article-title":"Predicting adverse outcomes in women with severe pre-eclampsia","volume":"33","author":"Menzies","year":"2009","journal-title":"Semin. Perinatol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Thangaratinam, S., Allotey, J., Marlin, N., Dodds, J., Cheong-See, F., von Dadelszen, P., Ganzevoort, W., Akkermans, J., Kerry, S., and Mol, B.W. (2017). PREP Collaborative Network. Prediction of complications in early-onset pre-eclampsia (PREP): Development and external multinational validation of prognostic models. BMC Med., 15.","DOI":"10.1186\/s12916-017-0827-3"},{"key":"ref_88","first-page":"1060","article-title":"Prediction models in obstetrics: Understanding the treatment paradox and potential solutions to the threat it poses","volume":"123","author":"Allotey","year":"2015","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.5315","article-title":"Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation","volume":"32","author":"Figueras","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/uog.20157","article-title":"Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio","volume":"53","author":"Ciobanu","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/972\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:59:00Z","timestamp":1760119140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/2\/972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["ijms24020972"],"URL":"https:\/\/doi.org\/10.3390\/ijms24020972","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}